HYDROXYZINE PAMOATE

HYDROXYZINE PAMOATE was reported 3677 times

HYDROXYZINE PAMOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FACTOR IX INHIBITION 3 0.0242
1 MASTOCYTOSIS 11 0.0233
2 INFECTIVE GLOSSITIS 3 0.0192
3 PERFUME SENSITIVITY 10 0.0176
4 HOMELESS 6 0.0135
5 ENGRAFT FAILURE 3 0.0105
6 DERMOID CYST 3 0.0090
7 HEMIHYPOAESTHESIA 3 0.0085
8 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
9 COMPULSIVE SEXUAL BEHAVIOUR 6 0.0074
10 TOOTH EROSION 9 0.0073
11 GAMBLING DISORDER 19 0.0070
12 TRICHOTILLOMANIA 4 0.0068
13 DIVORCED 3 0.0068
14 BANKRUPTCY 3 0.0067
15 ABDOMINOPLASTY 2 0.0060
16 MORNING SICKNESS 3 0.0055
17 COMPULSIVE SHOPPING 11 0.0053
18 VACCINATION SITE PAIN 3 0.0052
19 RETINAL PIGMENTATION 4 0.0051
20 DERMATILLOMANIA 3 0.0050
21 FAT NECROSIS 3 0.0049
22 MUCOSAL DISCOLOURATION 3 0.0047
23 DRUG DETOXIFICATION 4 0.0045
24 NEUROPSYCHIATRIC SYMPTOMS 4 0.0044
25 RESPIRATORY ARREST 117 0.0042
26 MYOFASCIAL PAIN SYNDROME 3 0.0042
27 ESCHAR 3 0.0041
28 ESSENTIAL HYPERTENSION 7 0.0038
29 COMPLETED SUICIDE 307 0.0037
30 REBOUND ACID HYPERSECRETION 11 0.0036
31 HYPERPARATHYROIDISM SECONDARY 9 0.0036
32 GENITAL BURNING SENSATION 3 0.0035
33 ENDOCRINE OPHTHALMOPATHY 3 0.0035
34 SELF-DESTRUCTIVE BEHAVIOUR 3 0.0034
35 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
36 BLOOD ALKALINE PHOSPHATASE ABNORMAL 3 0.0033
37 PRODUCT APPEARANCE CONFUSION 3 0.0032
38 PSYCHOGENIC SEIZURE 3 0.0032
39 WAIST CIRCUMFERENCE INCREASED 3 0.0029
40 NEPHROGENIC ANAEMIA 13 0.0028
41 PRODUCT ADMINISTRATION INTERRUPTED 22 0.0028
42 SOMATIC SYMPTOM DISORDER 3 0.0028
43 ACARODERMATITIS 3 0.0027
44 GENERALISED ANXIETY DISORDER 4 0.0027
45 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
46 SKIN DISCOMFORT 7 0.0026
47 CHRONIC SPONTANEOUS URTICARIA 3 0.0026
48 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
49 CHRONIC RESPIRATORY FAILURE 3 0.0025
50 POST-TRAUMATIC STRESS DISORDER 16 0.0024
51 ADJUSTMENT DISORDER 3 0.0023
52 IMPRISONMENT 4 0.0023
53 CARBON DIOXIDE INCREASED 3 0.0022
54 MAST CELL ACTIVATION SYNDROME 3 0.0021
55 BLADDER SPASM 4 0.0021
56 CONNECTIVE TISSUE DISORDER 3 0.0021
57 ACTINOMYCOSIS 2 0.0021
58 SEBORRHOEIC KERATOSIS 3 0.0021
59 ATROPHY 4 0.0021
60 CONJUNCTIVITIS ALLERGIC 3 0.0020
61 EAR SWELLING 4 0.0019
62 ALCOHOLISM 8 0.0019
63 AORTIC VALVE DISEASE 3 0.0019
64 ECONOMIC PROBLEM 28 0.0018
65 SPLENIC RUPTURE 3 0.0018
66 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
67 LIGAMENT RUPTURE 8 0.0018
68 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
69 ACUTE SINUSITIS 3 0.0017
70 SUSPECTED SUICIDE 8 0.0017
71 MITRAL VALVE DISEASE 3 0.0017
72 MACULOPATHY 6 0.0017
73 PANCREATITIS CHRONIC 4 0.0017
74 IMPAIRED GASTRIC EMPTYING 23 0.0017
75 IMPAIRED QUALITY OF LIFE 24 0.0017
76 BIPOLAR DISORDER 18 0.0017
77 LOSS OF EMPLOYMENT 5 0.0017
78 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
79 DRUG ABUSE 136 0.0016
80 OESOPHAGEAL SPASM 3 0.0016
81 OBSESSIVE-COMPULSIVE DISORDER 13 0.0016
82 PRE-EXISTING CONDITION IMPROVED 10 0.0016
83 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
84 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
85 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
86 EXCORIATION 4 0.0016
87 RHINITIS ALLERGIC 7 0.0016
88 DIABETIC COMPLICATION 4 0.0016
89 PANCREATIC CYST 3 0.0016
90 MEAN CELL VOLUME INCREASED 4 0.0016
91 HEPATIC MASS 3 0.0016
92 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 26 0.0015
93 CARDIAC ARREST 126 0.0015
94 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
95 SCRATCH 16 0.0015
96 REBOUND ECZEMA 3 0.0015
97 IMPULSE-CONTROL DISORDER 3 0.0015
98 PHYSICAL ASSAULT 3 0.0014
99 CHRONIC KIDNEY DISEASE 106 0.0014
100 STRABISMUS 4 0.0014
101 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
102 DISTRIBUTIVE SHOCK 3 0.0013
103 HYPERLIPIDAEMIA 15 0.0013
104 ACUTE LEUKAEMIA 2 0.0012
105 PRODUCT PACKAGING CONFUSION 3 0.0012
106 MAJOR DEPRESSION 9 0.0012
107 LYMPHOCYTE COUNT INCREASED 4 0.0012
108 INFUSION SITE HAEMORRHAGE 4 0.0012
109 STAPHYLOCOCCAL SEPSIS 6 0.0012
110 SKIN INJURY 4 0.0012
111 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
112 ANXIETY DISORDER 4 0.0012
113 SKIN PLAQUE 10 0.0012
114 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
115 DIABETIC RETINOPATHY 4 0.0012
116 AORTIC VALVE INCOMPETENCE 5 0.0012
117 ABNORMAL UTERINE BLEEDING 3 0.0012
118 END STAGE RENAL DISEASE 21 0.0012
119 DIVERTICULUM INTESTINAL 5 0.0011
120 ANHEDONIA 30 0.0011
121 SCOLIOSIS 7 0.0011
122 OBESITY 18 0.0011
123 AUTOIMMUNE DISORDER 11 0.0011
124 ALCOHOL ABUSE 3 0.0011
125 ALCOHOL POISONING 3 0.0011
126 GASTROINTESTINAL INJURY 3 0.0011
127 MIGRAINE WITH AURA 3 0.0011
128 EAR DISORDER 5 0.0011
129 RED BLOOD CELL COUNT INCREASED 3 0.0011
130 DENTAL CARIES 12 0.0011
131 DRUG SCREEN FALSE POSITIVE 3 0.0011
132 SERUM SICKNESS 3 0.0011
133 ACCIDENTAL DEATH 2 0.0011
134 FEELING OF DESPAIR 5 0.0011
135 ELECTRIC SHOCK SENSATION 3 0.0011
136 PSYCHOMOTOR RETARDATION 3 0.0011
137 TEMPERATURE INTOLERANCE 11 0.0011
138 SKIN REACTION 15 0.0011
139 AUTOIMMUNE THYROIDITIS 4 0.0011
140 ENDOMETRIOSIS 5 0.0010
141 RHINOVIRUS INFECTION 4 0.0010
142 SPINAL OSTEOARTHRITIS 9 0.0010
143 NECK INJURY 3 0.0010
144 POLYDIPSIA 4 0.0010
145 HYPERPHAGIA 4 0.0010
146 FRUSTRATION TOLERANCE DECREASED 8 0.0010
147 EYE INJURY 3 0.0010
148 TOXIC ENCEPHALOPATHY 5 0.0010
149 GOITRE 4 0.0010
150 TALIPES 3 0.0010
151 SUICIDAL BEHAVIOUR 4 0.0010
152 NON-CARDIAC CHEST PAIN 3 0.0009
153 HEPATIC PAIN 4 0.0009
154 OVERWEIGHT 5 0.0009
155 SEASONAL ALLERGY 13 0.0009
156 SOMNAMBULISM 6 0.0009
157 INTENTIONAL DOSE OMISSION 26 0.0009
158 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
159 NEPHRITIS 3 0.0009
160 CHOLECYSTITIS CHRONIC 6 0.0009
161 ENCEPHALOPATHY 22 0.0009
162 EATING DISORDER 19 0.0009
163 TRICUSPID VALVE INCOMPETENCE 7 0.0009
164 GRANULOCYTOPENIA 5 0.0009
165 ABDOMINAL HERNIA 4 0.0009
166 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
167 MENTAL DISORDER 38 0.0009
168 POST PROCEDURAL INFECTION 7 0.0009
169 CARPAL TUNNEL SYNDROME 12 0.0009
170 HYPERAESTHESIA 7 0.0009
171 HAND FRACTURE 6 0.0008
172 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
173 APPARENT DEATH 3 0.0008
174 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
175 RENAL TUBULAR NECROSIS 8 0.0008
176 PSYCHIATRIC SYMPTOM 6 0.0008
177 FOOT OPERATION 4 0.0008
178 TYPE 2 DIABETES MELLITUS 27 0.0008
179 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
180 PEMPHIGOID 6 0.0008
181 SNORING 3 0.0008
182 PARANASAL SINUS DISCOMFORT 3 0.0008
183 CLAVICLE FRACTURE 3 0.0008
184 ABDOMINAL INFECTION 2 0.0008
185 DISSOCIATION 6 0.0008
186 CONGENITAL ANOMALY 6 0.0008
187 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
188 PANIC DISORDER 3 0.0008
189 RENAL INJURY 23 0.0008
190 HIATUS HERNIA 10 0.0008
191 ACTINIC KERATOSIS 2 0.0008
192 HAEMORRHOIDS 15 0.0008
193 EPIGASTRIC DISCOMFORT 3 0.0008
194 WEIGHT FLUCTUATION 8 0.0008
195 INCREASED TENDENCY TO BRUISE 7 0.0008
196 SKIN MASS 5 0.0007
197 INTRACRANIAL ANEURYSM 3 0.0007
198 FUNGAL SKIN INFECTION 3 0.0007
199 BRUXISM 4 0.0007
200 GINGIVITIS 4 0.0007
201 STRESS FRACTURE 4 0.0007
202 HOMICIDAL IDEATION 3 0.0007
203 FOOT FRACTURE 14 0.0007
204 OESOPHAGITIS 8 0.0007
205 ARTHRITIS BACTERIAL 3 0.0007
206 ECCHYMOSIS 5 0.0007
207 SPINAL STENOSIS 3 0.0007
208 HUNGER 10 0.0007
209 VITAMIN D DEFICIENCY 7 0.0007
210 MALNUTRITION 8 0.0007
211 ANKLE FRACTURE 11 0.0007
212 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
213 URTICARIA 118 0.0007
214 VENTRICULAR SEPTAL DEFECT 4 0.0007
215 MIDDLE INSOMNIA 13 0.0007
216 BLOOD MAGNESIUM DECREASED 6 0.0007
217 NEUTROPHIL COUNT INCREASED 7 0.0007
218 SEXUAL DYSFUNCTION 8 0.0007
219 EAR DISCOMFORT 7 0.0007
220 RIB FRACTURE 14 0.0007
221 GINGIVAL SWELLING 3 0.0007
222 SEROTONIN SYNDROME 13 0.0007
223 MENINGITIS ASEPTIC 3 0.0007
224 WRIST FRACTURE 8 0.0007
225 ANAL INCONTINENCE 6 0.0007
226 SLEEP DISORDER 47 0.0007
227 LIMB INJURY 18 0.0007
228 RENAL PAIN 7 0.0007
229 NOCTURIA 8 0.0007
230 PANIC ATTACK 24 0.0007
231 HAEMATOCRIT DECREASED 13 0.0007
232 RENAL FAILURE 87 0.0007
233 DRUG ABUSER 4 0.0007
234 MENISCUS INJURY 4 0.0006
235 IRON DEFICIENCY ANAEMIA 6 0.0006
236 ARTHRITIS INFECTIVE 3 0.0006
237 ROSACEA 3 0.0006
238 MULTIPLE MYELOMA 3 0.0006
239 BRAIN FOG 10 0.0006
240 AFFECTIVE DISORDER 5 0.0006
241 NEPHROLITHIASIS 29 0.0006
242 OSTEOPOROSIS 26 0.0006
243 PRE-ECLAMPSIA 3 0.0006
244 RENAL CYST 5 0.0006
245 SLEEP APNOEA SYNDROME 12 0.0006
246 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
247 OCULAR DISCOMFORT 7 0.0006
248 PROCTALGIA 4 0.0006
249 PRESCRIBED OVERDOSE 12 0.0006
250 CARDIAC FLUTTER 4 0.0006
251 DIPLOPIA 16 0.0006
252 INCORRECT DOSAGE ADMINISTERED 3 0.0006
253 PHARYNGEAL SWELLING 6 0.0006
254 ACUTE KIDNEY INJURY 93 0.0006
255 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
256 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
257 HYPERVOLAEMIA 3 0.0006
258 PULMONARY CONGESTION 8 0.0006
259 PHOTOSENSITIVITY REACTION 10 0.0006
260 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
261 RESTLESS LEGS SYNDROME 11 0.0006
262 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
263 ATRIAL SEPTAL DEFECT 5 0.0006
264 BREAST MASS 4 0.0006
265 ANXIETY 169 0.0006
266 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
267 HERPES ZOSTER 34 0.0006
268 AMMONIA INCREASED 3 0.0006
269 VITAMIN D DECREASED 5 0.0006
270 EMOTIONAL DISORDER 18 0.0006
271 INTESTINAL OBSTRUCTION 22 0.0006
272 MUSCULOSKELETAL DISORDER 11 0.0006
273 CARDIAC MURMUR 5 0.0006
274 NEURALGIA 14 0.0006
275 ILLNESS 59 0.0006
276 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
277 GASTRITIS 15 0.0006
278 CARDIOMEGALY 7 0.0006
279 PAPULE 4 0.0006
280 HALLUCINATION, AUDITORY 9 0.0006
281 MIGRAINE 54 0.0006
282 JOINT INJURY 12 0.0006
283 NASAL CONGESTION 33 0.0006
284 FOOD POISONING 3 0.0006
285 POOR QUALITY SLEEP 12 0.0006
286 DISCOMFORT 34 0.0006
287 CHEILITIS 3 0.0006
288 HIP SURGERY 3 0.0006
289 VISUAL FIELD DEFECT 4 0.0006
290 BLOOD PRESSURE ABNORMAL 11 0.0006
291 TIC 3 0.0005
292 DERMATITIS ATOPIC 29 0.0005
293 SUICIDE ATTEMPT 33 0.0005
294 CHOKING SENSATION 3 0.0005
295 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
296 ARTHROPOD BITE 4 0.0005
297 BLOOD CALCIUM DECREASED 6 0.0005
298 ASTHMA 60 0.0005
299 MITRAL VALVE INCOMPETENCE 6 0.0005
300 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
301 PERONEAL NERVE PALSY 3 0.0005
302 SPINAL DISORDER 5 0.0005
303 CARDIAC VALVE DISEASE 3 0.0005
304 INCREASED APPETITE 10 0.0005
305 INSURANCE ISSUE 8 0.0005
306 CRYING 19 0.0005
307 SKIN ATROPHY 3 0.0005
308 LOWER LIMB FRACTURE 10 0.0005
309 RENAL FAILURE CHRONIC 4 0.0005
310 MOUTH SWELLING 3 0.0005
311 ACUTE RESPIRATORY FAILURE 10 0.0005
312 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
313 FOOD ALLERGY 4 0.0005
314 SINUS CONGESTION 7 0.0005
315 ATELECTASIS 5 0.0005
316 NERVOUSNESS 27 0.0005
317 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
318 CONCUSSION 4 0.0005
319 DELUSION 8 0.0005
320 NEUROTOXICITY 9 0.0005
321 HYPOVOLAEMIA 3 0.0005
322 DIABETES MELLITUS 39 0.0005
323 MULTIPLE ALLERGIES 4 0.0005
324 DECREASED INTEREST 3 0.0005
325 DEPRESSION 115 0.0005
326 SINUS HEADACHE 3 0.0005
327 UNRESPONSIVE TO STIMULI 13 0.0005
328 RESPIRATORY TRACT CONGESTION 8 0.0005
329 HYPOMAGNESAEMIA 7 0.0005
330 ANGER 17 0.0005
331 SUICIDAL IDEATION 46 0.0005
332 HYPOTONIA 5 0.0005
333 TARDIVE DYSKINESIA 14 0.0005
334 BONE DISORDER 9 0.0005
335 SCHIZOPHRENIA 6 0.0005
336 SHOCK HAEMORRHAGIC 4 0.0005
337 EYE DISCHARGE 5 0.0005
338 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
339 BLOOD UREA INCREASED 8 0.0005
340 BLEPHAROSPASM 3 0.0005
341 MULTIPLE INJURIES 3 0.0005
342 HAEMODIALYSIS 4 0.0005
343 INJECTION SITE DISCOMFORT 5 0.0005
344 SKIN HAEMORRHAGE 7 0.0005
345 ROTATOR CUFF SYNDROME 6 0.0005
346 FEELING COLD 13 0.0005
347 PRODUCT CONTAINER ISSUE 4 0.0005
348 HAEMOGLOBIN ABNORMAL 3 0.0005
349 BONE LOSS 7 0.0005
350 PHARYNGITIS STREPTOCOCCAL 5 0.0005
351 PYELONEPHRITIS 4 0.0005
352 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
353 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
354 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
355 SEDATION 12 0.0005
356 HYPOGAMMAGLOBULINAEMIA 3 0.0005
357 TOOTH INFECTION 6 0.0005
358 STAPHYLOCOCCAL INFECTION 15 0.0005
359 SARS-COV-2 TEST POSITIVE 6 0.0005
360 THYROID DISORDER 7 0.0005
361 PANCREATITIS 24 0.0005
362 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
363 FIBROMYALGIA 11 0.0005
364 MENINGITIS 3 0.0004
365 FOREIGN BODY IN REPRODUCTIVE TRACT 4 0.0004
366 QUALITY OF LIFE DECREASED 6 0.0004
367 BONE DENSITY DECREASED 14 0.0004
368 EMOTIONAL DISTRESS 54 0.0004
369 DYSSTASIA 13 0.0004
370 FEEDING DISORDER 9 0.0004
371 PRODUCT LABEL ISSUE 3 0.0004
372 DRY EYE 22 0.0004
373 ULCER 7 0.0004
374 IMPAIRED DRIVING ABILITY 5 0.0004
375 PRURITUS 169 0.0004
376 BLOOD TESTOSTERONE DECREASED 3 0.0004
377 MICTURITION URGENCY 5 0.0004
378 NEPHROTIC SYNDROME 3 0.0004
379 JOINT EFFUSION 3 0.0004
380 UROSEPSIS 4 0.0004
381 NERVE COMPRESSION 4 0.0004
382 MENTAL STATUS CHANGES 12 0.0004
383 FORMICATION 3 0.0004
384 DERMATITIS 9 0.0004
385 HEPATIC STEATOSIS 8 0.0004
386 COGNITIVE DISORDER 20 0.0004
387 KNEE ARTHROPLASTY 9 0.0004
388 CHOLELITHIASIS 14 0.0004
389 LACERATION 4 0.0004
390 ARTERIOSCLEROSIS 4 0.0004
391 DIVERTICULUM 3 0.0004
392 SPUTUM DISCOLOURED 4 0.0004
393 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
394 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
395 BLOOD IRON DECREASED 5 0.0004
396 ATAXIA 5 0.0004
397 IMPAIRED WORK ABILITY 9 0.0004
398 FEAR OF INJECTION 3 0.0004
399 FEELING JITTERY 8 0.0004
400 IRRITABLE BOWEL SYNDROME 9 0.0004
401 RASH ERYTHEMATOUS 20 0.0004
402 INSOMNIA 110 0.0004
403 BURSITIS 5 0.0004
404 HYPERGLYCAEMIA 15 0.0004
405 RESTLESSNESS 15 0.0004
406 SCAR 7 0.0004
407 CYSTITIS 13 0.0004
408 RESPIRATORY DEPRESSION 5 0.0004
409 BLOOD CHOLESTEROL INCREASED 19 0.0004
410 SOMNOLENCE 82 0.0004
411 SEIZURE 47 0.0004
412 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
413 BLINDNESS TRANSIENT 3 0.0004
414 METABOLIC ACIDOSIS 13 0.0004
415 NIGHTMARE 14 0.0004
416 DISABILITY 8 0.0004
417 EMBEDDED DEVICE 4 0.0004
418 FEELING DRUNK 3 0.0004
419 INABILITY TO AFFORD MEDICATION 4 0.0004
420 HEPATIC FUNCTION ABNORMAL 15 0.0004
421 LACTIC ACIDOSIS 13 0.0004
422 PNEUMONIA ASPIRATION 10 0.0004
423 SINUSITIS 41 0.0004
424 POISONING 5 0.0004
425 SLUGGISHNESS 4 0.0004
426 GALLBLADDER DISORDER 7 0.0004
427 BOWEL MOVEMENT IRREGULARITY 3 0.0004
428 TOXICITY TO VARIOUS AGENTS 66 0.0004
429 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
430 INITIAL INSOMNIA 4 0.0004
431 DEVICE RELATED INFECTION 6 0.0004
432 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
433 ANOREXIA 5 0.0004
434 ABDOMINAL DISCOMFORT 65 0.0004
435 RHINORRHOEA 25 0.0004
436 TOOTHACHE 7 0.0004
437 POOR VENOUS ACCESS 4 0.0004
438 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
439 HYPERBILIRUBINAEMIA 4 0.0004
440 TOOTH LOSS 8 0.0004
441 PELVIC FRACTURE 3 0.0004
442 CONSTIPATION 84 0.0004
443 SWELLING 36 0.0004
444 TENDERNESS 4 0.0004
445 HYPERSOMNIA 11 0.0004
446 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
447 TORSADE DE POINTES 3 0.0004
448 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
449 DRY MOUTH 31 0.0004
450 RENAL IMPAIRMENT 32 0.0004
451 DYSURIA 14 0.0004
452 ORAL CANDIDIASIS 5 0.0004
453 HEAD INJURY 12 0.0004
454 NASAL DISCOMFORT 3 0.0004
455 JOINT DISLOCATION 4 0.0004
456 BLOOD ALBUMIN DECREASED 3 0.0004
457 PRODUCT DOSE OMISSION ISSUE 111 0.0004
458 CONJUNCTIVITIS 7 0.0004
459 GINGIVAL PAIN 3 0.0004
460 DYSPEPSIA 37 0.0004
461 BONE PAIN 22 0.0004
462 SURGERY 22 0.0004
463 BREAST PAIN 4 0.0004
464 INTENTIONAL OVERDOSE 24 0.0004
465 FEAR 10 0.0004
466 DECREASED ACTIVITY 4 0.0004
467 FRACTURE 7 0.0004
468 DYSKINESIA 15 0.0004
469 OEDEMA 20 0.0004
470 SUBSTANCE ABUSE 3 0.0004
471 NEUROPATHY PERIPHERAL 35 0.0004
472 SKIN LACERATION 4 0.0004
473 TREMOR 61 0.0004
474 AKATHISIA 5 0.0004
475 BLOOD POTASSIUM DECREASED 11 0.0004
476 HICCUPS 3 0.0004
477 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
478 WOUND INFECTION 4 0.0004
479 MULTIPLE SCLEROSIS RELAPSE 25 0.0004
480 MANIA 6 0.0004
481 CORONARY ARTERY OCCLUSION 5 0.0004
482 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
483 GASTROINTESTINAL PAIN 4 0.0004
484 CONTUSION 35 0.0004
485 ABNORMAL DREAMS 10 0.0004
486 ANAPHYLACTIC REACTION 20 0.0004
487 BLOOD PRESSURE DECREASED 24 0.0004
488 FOOT DEFORMITY 4 0.0004
489 EOSINOPHIL COUNT INCREASED 3 0.0004
490 TOOTH DISORDER 8 0.0004
491 DYSPHAGIA 34 0.0004
492 FALL 119 0.0004
493 SKIN INFECTION 4 0.0004
494 SENSATION OF FOREIGN BODY 3 0.0004
495 INJURY 25 0.0004
496 MULTIPLE SCLEROSIS 17 0.0004
497 BLINDNESS UNILATERAL 5 0.0004
498 AGITATION 26 0.0004
499 AMNESIA 23 0.0004
500 SINUS TACHYCARDIA 5 0.0004
501 FACIAL PARALYSIS 3 0.0004
502 DERMATITIS CONTACT 4 0.0004
503 RED BLOOD CELL COUNT DECREASED 10 0.0003
504 IRRITABILITY 21 0.0003
505 RASH 152 0.0003
506 PARANOIA 6 0.0003
507 MUSCLE STRAIN 3 0.0003
508 DYSARTHRIA 13 0.0003
509 ECZEMA 18 0.0003
510 SPLENOMEGALY 4 0.0003
511 TUMOUR LYSIS SYNDROME 3 0.0003
512 GRIP STRENGTH DECREASED 3 0.0003
513 HYPOXIA 12 0.0003
514 COLD SWEAT 6 0.0003
515 BRADYCARDIA 18 0.0003
516 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
517 WEIGHT DECREASED 94 0.0003
518 PULMONARY MASS 5 0.0003
519 PRODUCTIVE COUGH 16 0.0003
520 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
521 FREQUENT BOWEL MOVEMENTS 9 0.0003
522 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
523 DECREASED APPETITE 77 0.0003
524 FUNGAL INFECTION 11 0.0003
525 URINARY RETENTION 11 0.0003
526 OSTEOPENIA 5 0.0003
527 GAIT INABILITY 11 0.0003
528 RETCHING 7 0.0003
529 LIVER FUNCTION TEST INCREASED 7 0.0003
530 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
531 SPINAL OPERATION 4 0.0003
532 BALANCE DISORDER 28 0.0003
533 PRURITUS GENERALISED 7 0.0003
534 PRODUCT DISTRIBUTION ISSUE 3 0.0003
535 HAEMOPTYSIS 9 0.0003
536 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
537 PRODUCT DISPENSING ERROR 7 0.0003
538 NASOPHARYNGITIS 59 0.0003
539 AGGRESSION 16 0.0003
540 SECRETION DISCHARGE 4 0.0003
541 HEPATIC CIRRHOSIS 6 0.0003
542 PHOTOPHOBIA 6 0.0003
543 BLOOD SODIUM DECREASED 6 0.0003
544 MUSCULAR WEAKNESS 36 0.0003
545 PAIN 194 0.0003
546 MUSCLE ATROPHY 4 0.0003
547 LIVER DISORDER 14 0.0003
548 HAEMATEMESIS 8 0.0003
549 CONVULSION 18 0.0003
550 MOOD SWINGS 10 0.0003
551 RASH PRURITIC 17 0.0003
552 SCIATICA 5 0.0003
553 STOMATITIS 19 0.0003
554 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
555 GASTROINTESTINAL DISORDER 28 0.0003
556 VERTIGO 19 0.0003
557 BRONCHITIS 23 0.0003
558 NIGHT SWEATS 10 0.0003
559 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
560 HEART RATE IRREGULAR 7 0.0003
561 WITHDRAWAL SYNDROME 13 0.0003
562 DIZZINESS POSTURAL 3 0.0003
563 DYSTONIA 6 0.0003
564 WEIGHT INCREASED 69 0.0003
565 THROMBOTIC MICROANGIOPATHY 3 0.0003
566 DEHYDRATION 41 0.0003
567 SKIN FISSURES 6 0.0003
568 PLATELET COUNT INCREASED 4 0.0003
569 BLOOD CREATININE INCREASED 20 0.0003
570 VITREOUS FLOATERS 3 0.0003
571 URINARY TRACT INFECTION 52 0.0003
572 TINNITUS 14 0.0003
573 FEELING ABNORMAL 73 0.0003
574 LOSS OF CONSCIOUSNESS 39 0.0003
575 MULTIPLE FRACTURES 5 0.0003
576 BEDRIDDEN 4 0.0003
577 NECK PAIN 17 0.0003
578 LIGAMENT SPRAIN 3 0.0003
579 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
580 SINUS DISORDER 6 0.0003
581 HEART RATE INCREASED 30 0.0003
582 RECTAL HAEMORRHAGE 13 0.0003
583 OROPHARYNGEAL PAIN 28 0.0003
584 EYE PAIN 17 0.0003
585 CYTOMEGALOVIRUS INFECTION 5 0.0003
586 PRESCRIBED UNDERDOSE 6 0.0003
587 LIP SWELLING 10 0.0003
588 OVARIAN CYST 3 0.0003
589 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
590 BRAIN INJURY 3 0.0003
591 PSORIASIS 39 0.0003
592 PERIPHERAL SWELLING 46 0.0003
593 GAIT DISTURBANCE 57 0.0003
594 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
595 INFECTION 43 0.0003
596 BACK PAIN 69 0.0003
597 CHEST PAIN 55 0.0003
598 CANDIDA INFECTION 5 0.0003
599 TASTE DISORDER 6 0.0003
600 BLOOD PRESSURE INCREASED 45 0.0003
601 CIRCULATORY COLLAPSE 5 0.0003
602 ABNORMAL LOSS OF WEIGHT 2 0.0003
603 MOOD ALTERED 8 0.0003
604 HYPERTENSION 62 0.0003
605 DEEP VEIN THROMBOSIS 19 0.0003
606 HALLUCINATION 22 0.0003
607 SKIN LESION 8 0.0003
608 NAUSEA 230 0.0003
609 MUSCULOSKELETAL DISCOMFORT 5 0.0003
610 SKELETAL INJURY 3 0.0003
611 THERAPY NON-RESPONDER 13 0.0003
612 MENTAL IMPAIRMENT 7 0.0003
613 SWOLLEN TONGUE 9 0.0003
614 DELIRIUM 10 0.0003
615 PULMONARY HYPERTENSION 6 0.0003
616 PETECHIAE 3 0.0003
617 VOMITING 135 0.0003
618 CARDIO-RESPIRATORY ARREST 12 0.0003
619 ROAD TRAFFIC ACCIDENT 12 0.0003
620 MASS 4 0.0003
621 FOLLICULITIS 3 0.0003
622 HALLUCINATION, VISUAL 6 0.0003
623 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
624 INCONTINENCE 3 0.0003
625 DEPRESSED MOOD 15 0.0003
626 EPISTAXIS 21 0.0003
627 BODY HEIGHT DECREASED 3 0.0003
628 THIRST 5 0.0003
629 ABDOMINAL PAIN 65 0.0003
630 ARTHRALGIA 116 0.0003
631 FATIGUE 217 0.0003
632 INFLUENZA 31 0.0003
633 CELLULITIS 14 0.0003
634 PARAESTHESIA ORAL 4 0.0003
635 GASTROENTERITIS VIRAL 5 0.0003
636 ABDOMINAL PAIN UPPER 57 0.0003
637 LEUKOCYTOSIS 5 0.0003
638 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
639 BACK INJURY 3 0.0003
640 PELVIC PAIN 5 0.0003
641 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
642 INTENTIONAL PRODUCT MISUSE 24 0.0003
643 ASPIRATION 3 0.0003
644 MUSCLE SPASMS 50 0.0003
645 TOOTH FRACTURE 3 0.0003
646 ANGIOEDEMA 12 0.0003
647 HEADACHE 170 0.0003
648 NEUTROPHIL COUNT DECREASED 11 0.0003
649 WHEEZING 16 0.0003
650 NERVE INJURY 3 0.0003
651 HYPERTENSIVE CRISIS 3 0.0003
652 OVERDOSE 58 0.0003
653 RESPIRATORY TRACT INFECTION 7 0.0003
654 DIZZINESS 134 0.0003
655 THINKING ABNORMAL 5 0.0003
656 IMMUNODEFICIENCY 4 0.0003
657 PAIN IN EXTREMITY 79 0.0003
658 BACTERIAL INFECTION 5 0.0003
659 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
660 JOINT STIFFNESS 7 0.0003
661 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
662 CHROMATURIA 6 0.0003
663 APHASIA 8 0.0003
664 HYPERHIDROSIS 34 0.0003
665 BLOOD URINE PRESENT 5 0.0003
666 CONDITION AGGRAVATED 80 0.0003
667 PLATELET COUNT DECREASED 28 0.0003
668 MUSCULOSKELETAL STIFFNESS 23 0.0003
669 ACIDOSIS 2 0.0003
670 SKIN DISCOLOURATION 12 0.0003
671 NEOPLASM 3 0.0003
672 SKIN EXFOLIATION 22 0.0003
673 COUGH 73 0.0003
674 MUSCLE TWITCHING 6 0.0003
675 THROAT TIGHTNESS 7 0.0003
676 HYPERSENSITIVITY 48 0.0003
677 ERUCTATION 5 0.0003
678 TENDONITIS 4 0.0003
679 BURNING SENSATION 18 0.0003
680 THERAPY PARTIAL RESPONDER 4 0.0003
681 SPINAL PAIN 3 0.0003
682 FLUID RETENTION 13 0.0003
683 KIDNEY INFECTION 5 0.0003
684 PARAESTHESIA 40 0.0003
685 COVID-19 PNEUMONIA 3 0.0003
686 HYPOAESTHESIA 38 0.0003
687 ASTHENIA 95 0.0003
688 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
689 PROCEDURAL PAIN 7 0.0003
690 PRODUCT PRESCRIBING ERROR 6 0.0003
691 INFLAMMATION 13 0.0003
692 MYOCLONUS 3 0.0003
693 PYREXIA 87 0.0003
694 ACCIDENT 3 0.0003
695 UPPER LIMB FRACTURE 5 0.0003
696 HYPOTHYROIDISM 8 0.0003
697 PRODUCT USE IN UNAPPROVED INDICATION 62 0.0002
698 DIABETIC KETOACIDOSIS 6 0.0002
699 SPINAL FRACTURE 5 0.0002
700 SPEECH DISORDER 13 0.0002
701 INTENTIONAL SELF-INJURY 5 0.0002
702 HOSPITALISATION 38 0.0002
703 ADRENAL INSUFFICIENCY 3 0.0002
704 MUSCLE TIGHTNESS 4 0.0002
705 PRESYNCOPE 6 0.0002
706 NO THERAPEUTIC RESPONSE 3 0.0002
707 BACK DISORDER 4 0.0002
708 BODY TEMPERATURE INCREASED 5 0.0002
709 FEELING HOT 15 0.0002
710 EYE DISORDER 8 0.0002
711 VENTRICULAR TACHYCARDIA 4 0.0002
712 EYE SWELLING 9 0.0002
713 PHARYNGITIS 3 0.0002
714 CYST 3 0.0002
715 EXTRAPYRAMIDAL DISORDER 6 0.0002
716 CONFUSIONAL STATE 39 0.0002
717 FEBRILE NEUTROPENIA 16 0.0002
718 PNEUMONIA 78 0.0002
719 MEMORY IMPAIRMENT 33 0.0002
720 COAGULOPATHY 4 0.0002
721 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
722 DRUG INTERACTION 38 0.0002
723 COVID-19 42 0.0002
724 THERAPY INTERRUPTED 17 0.0002
725 PSYCHOTIC DISORDER 7 0.0002
726 CARDIAC FAILURE CONGESTIVE 19 0.0002
727 HEMIPARESIS 4 0.0002
728 CHEST DISCOMFORT 24 0.0002
729 HYPOTENSION 47 0.0002
730 INFUSION SITE PAIN 3 0.0002
731 INJECTION SITE REACTION 16 0.0002
732 LACRIMATION INCREASED 7 0.0002
733 RASH GENERALISED 6 0.0002
734 OXYGEN SATURATION DECREASED 13 0.0002
735 CORONARY ARTERY DISEASE 7 0.0002
736 THERAPEUTIC RESPONSE DECREASED 14 0.0002
737 DEVICE DEFECTIVE 4 0.0002
738 NODULE 3 0.0002
739 PRODUCT DOSE OMISSION 15 0.0002
740 DIARRHOEA 148 0.0002
741 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
742 IMMUNE SYSTEM DISORDER 3 0.0002
743 ABNORMAL BEHAVIOUR 9 0.0002
744 LYMPHOCYTE COUNT DECREASED 4 0.0002
745 LIMB DISCOMFORT 7 0.0002
746 LETHARGY 13 0.0002
747 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
748 MALAISE 99 0.0002
749 DRUG ERUPTION 4 0.0002
750 HOT FLUSH 17 0.0002
751 MALIGNANT MELANOMA 3 0.0002
752 DRUG DEPENDENCE 36 0.0002
753 JOINT RANGE OF MOTION DECREASED 3 0.0002
754 JOINT SWELLING 27 0.0002
755 PULMONARY OEDEMA 10 0.0002
756 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
757 COMPLICATION OF DEVICE REMOVAL 4 0.0002
758 RHEUMATOID ARTHRITIS 25 0.0002
759 PRODUCT AVAILABILITY ISSUE 5 0.0002
760 RESPIRATORY FAILURE 16 0.0002
761 TREATMENT NONCOMPLIANCE 12 0.0002
762 DRUG INEFFECTIVE 288 0.0002
763 PRODUCT USE ISSUE 41 0.0002
764 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
765 DRUG INTOLERANCE 21 0.0002
766 BLOOD GLUCOSE ABNORMAL 4 0.0002
767 FLUSHING 22 0.0002
768 INJECTION SITE MASS 8 0.0002
769 PERICARDIAL EFFUSION 5 0.0002
770 POLLAKIURIA 9 0.0002
771 SEPSIS 24 0.0002
772 COORDINATION ABNORMAL 3 0.0002
773 ANAEMIA 41 0.0002
774 WOUND 6 0.0002
775 RENAL DISORDER 10 0.0002
776 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
777 HAEMOGLOBIN DECREASED 22 0.0002
778 OSTEOARTHRITIS 9 0.0002
779 DIALYSIS 3 0.0002
780 VISION BLURRED 29 0.0002
781 ABDOMINAL DISTENSION 22 0.0002
782 VIRAL INFECTION 7 0.0002
783 BRONCHOSPASM 3 0.0002
784 COMA 10 0.0002
785 SKIN DISORDER 7 0.0002
786 SUBDURAL HAEMATOMA 3 0.0002
787 ANGINA PECTORIS 6 0.0002
788 CARDIOGENIC SHOCK 3 0.0002
789 EYE IRRITATION 12 0.0002
790 BLOOD PRESSURE FLUCTUATION 5 0.0002
791 POST PROCEDURAL COMPLICATION 4 0.0002
792 ANOSMIA 3 0.0002
793 HYPERTHYROIDISM 3 0.0002
794 HERNIA 4 0.0002
795 LOCALISED INFECTION 5 0.0002
796 INFLUENZA LIKE ILLNESS 17 0.0002
797 APATHY 3 0.0002
798 ORAL HERPES 4 0.0002
799 ARTHRITIS 16 0.0002
800 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
801 CATARACT 12 0.0002
802 SWELLING FACE 13 0.0002
803 FULL BLOOD COUNT DECREASED 4 0.0002
804 PRODUCT PHYSICAL ISSUE 4 0.0002
805 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
806 BLOOD COUNT ABNORMAL 3 0.0002
807 INFUSION RELATED REACTION 13 0.0002
808 DYSPNOEA 111 0.0002
809 PHARYNGEAL OEDEMA 3 0.0002
810 HYPOKALAEMIA 9 0.0002
811 DRY SKIN 26 0.0002
812 ERECTILE DYSFUNCTION 5 0.0002
813 INJECTION SITE PRURITUS 13 0.0002
814 MUSCULOSKELETAL CHEST PAIN 3 0.0002
815 FEMUR FRACTURE 6 0.0002
816 DRUG WITHDRAWAL SYNDROME 17 0.0002
817 EJECTION FRACTION DECREASED 3 0.0002
818 PRODUCT USE COMPLAINT 3 0.0002
819 PNEUMOTHORAX 3 0.0002
820 RENAL FAILURE ACUTE 8 0.0002
821 EAR INFECTION 5 0.0002
822 PALPITATIONS 22 0.0002
823 MOVEMENT DISORDER 6 0.0002
824 HYPOGLYCAEMIA 9 0.0002
825 UNEVALUABLE EVENT 14 0.0002
826 COLITIS 7 0.0002
827 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
828 OFF LABEL USE 161 0.0002
829 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
830 IMPAIRED HEALING 6 0.0002
831 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
832 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
833 CHILLS 21 0.0002
834 PULMONARY EMBOLISM 17 0.0002
835 RASH PAPULAR 4 0.0002
836 ADVERSE DRUG REACTION 16 0.0002
837 DISORIENTATION 7 0.0002
838 HEPATIC ENZYME INCREASED 12 0.0002
839 ERYTHEMA 36 0.0002
840 SKIN IRRITATION 8 0.0002
841 SHOCK 4 0.0002
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
843 ORTHOSTATIC HYPOTENSION 3 0.0002
844 LIVER FUNCTION TEST ABNORMAL 5 0.0002
845 NEEDLE ISSUE 5 0.0002
846 RASH MACULAR 6 0.0002
847 DEVICE USE ISSUE 3 0.0002
848 CEREBROVASCULAR ACCIDENT 29 0.0002
849 DYSPHONIA 10 0.0002
850 ACUTE MYOCARDIAL INFARCTION 5 0.0002
851 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
852 HEAD DISCOMFORT 3 0.0002
853 NEUTROPENIA 23 0.0002
854 OSTEOMYELITIS 3 0.0002
855 DRUG EFFECT INCOMPLETE 6 0.0002
856 C-REACTIVE PROTEIN INCREASED 6 0.0002
857 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
858 HAEMATOCHEZIA 9 0.0002
859 ALOPECIA 32 0.0002
860 ABNORMAL WEIGHT GAIN 2 0.0002
861 AGRANULOCYTOSIS 3 0.0002
862 DEVICE DISLOCATION 7 0.0002
863 AGEUSIA 4 0.0002
864 NERVOUS SYSTEM DISORDER 5 0.0002
865 SYNCOPE 16 0.0002
866 HYPONATRAEMIA 9 0.0002
867 BLOOD GLUCOSE INCREASED 30 0.0002
868 FLATULENCE 9 0.0002
869 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
870 ABDOMINAL PAIN LOWER 4 0.0002
871 GASTRIC ULCER 3 0.0002
872 THROAT IRRITATION 7 0.0002
873 THERAPY CESSATION 8 0.0002
874 GLAUCOMA 3 0.0002
875 HIP FRACTURE 5 0.0002
876 HAEMATOMA 4 0.0002
877 EAR PAIN 3 0.0002
878 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
879 INJECTION SITE PAIN 47 0.0002
880 MOBILITY DECREASED 11 0.0002
881 MYALGIA 26 0.0002
882 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
883 UNDERDOSE 11 0.0002
884 VISUAL ACUITY REDUCED 5 0.0002
885 EXPIRED PRODUCT ADMINISTERED 5 0.0002
886 THROMBOSIS 12 0.0001
887 INCORRECT DOSE ADMINISTERED 34 0.0001
888 DISTURBANCE IN ATTENTION 8 0.0001
889 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
890 DEVICE BREAKAGE 6 0.0001
891 BONE MARROW FAILURE 3 0.0001
892 BLINDNESS 6 0.0001
893 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
894 ACUTE HEPATIC FAILURE 2 0.0001
895 TACHYCARDIA 13 0.0001
896 PRODUCT PREPARATION ERROR 3 0.0001
897 HAEMATURIA 5 0.0001
898 DEPENDENCE 8 0.0001
899 RESPIRATORY DISTRESS 4 0.0001
900 ARTHROPATHY 8 0.0001
901 RHABDOMYOLYSIS 6 0.0001
902 INTENTIONAL DRUG MISUSE 3 0.0001
903 DEMENTIA 4 0.0001
904 BLISTER 8 0.0001
905 MOUTH ULCERATION 3 0.0001
906 LYMPHADENOPATHY 5 0.0001
907 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
908 LEUKOPENIA 7 0.0001
909 CARDIAC DISORDER 13 0.0001
910 FAECES DISCOLOURED 3 0.0001
911 SEPTIC SHOCK 6 0.0001
912 INJECTION SITE HAEMORRHAGE 11 0.0001
913 INJECTION SITE ERYTHEMA 17 0.0001
914 ASCITES 4 0.0001
915 URINARY INCONTINENCE 4 0.0001
916 COLITIS ULCERATIVE 6 0.0001
917 THROMBOCYTOPENIA 15 0.0001
918 GLOSSODYNIA 3 0.0001
919 ORAL PAIN 3 0.0001
920 ATRIAL FIBRILLATION 13 0.0001
921 PANCREATITIS ACUTE 3 0.0001
922 DYSPNOEA EXERTIONAL 5 0.0001
923 ILL-DEFINED DISORDER 8 0.0001
924 OEDEMA PERIPHERAL 16 0.0001
925 VISUAL IMPAIRMENT 16 0.0001
926 DEATH 110 0.0001
927 DISEASE PROGRESSION 15 0.0001
928 ARRHYTHMIA 6 0.0001
929 OCULAR HYPERAEMIA 6 0.0001
930 SKIN BURNING SENSATION 9 0.0001
931 ABSCESS 2 0.0001
932 BLOOD GLUCOSE DECREASED 6 0.0001
933 CARDIAC FAILURE 10 0.0001
934 EXTRA DOSE ADMINISTERED 5 0.0001
935 LUNG DISORDER 6 0.0001
936 PRODUCT SUBSTITUTION ISSUE 7 0.0001
937 MYOCARDIAL INFARCTION 21 0.0001
938 EYE PRURITUS 4 0.0001
939 CARDIOVASCULAR DISORDER 3 0.0001
940 INJECTION SITE SWELLING 9 0.0001
941 HYPOPHAGIA 3 0.0001
942 HEPATITIS 3 0.0001
943 GASTRIC DISORDER 4 0.0001
944 DEVICE LEAKAGE 5 0.0001
945 PLEURAL EFFUSION 7 0.0001
946 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
947 HYPERKALAEMIA 4 0.0001
948 HEART RATE DECREASED 4 0.0001
949 INJECTION SITE BRUISING 9 0.0001
950 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
951 DEVICE ISSUE 10 0.0001
952 BLOOD BILIRUBIN INCREASED 3 0.0001
953 PRODUCT QUALITY ISSUE 15 0.0001
954 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
955 ADVERSE EVENT 10 0.0001
956 DIVERTICULITIS 3 0.0001
957 DYSGEUSIA 8 0.0001
958 PANCYTOPENIA 6 0.0001
959 HAEMORRHAGE 11 0.0001
960 DISEASE RECURRENCE 5 0.0001
961 RESPIRATORY DISORDER 3 0.0001
962 ABORTION SPONTANEOUS 4 0.0001
963 PSORIATIC ARTHROPATHY 4 0.0001
964 INJECTION SITE RASH 3 0.0001
965 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
966 EXPOSURE DURING PREGNANCY 6 0.0001
967 MUSCULOSKELETAL PAIN 5 0.0001
968 HYPOACUSIS 4 0.0001
969 VAGINAL HAEMORRHAGE 4 0.0001
970 OSTEONECROSIS 3 0.0001
971 MEDICATION ERROR 5 0.0001
972 NEOPLASM PROGRESSION 3 0.0001
973 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
974 CEREBRAL HAEMORRHAGE 3 0.0001
975 ACCIDENTAL OVERDOSE 3 0.0001
976 ABASIA 2 0.0001
977 PLASMA CELL MYELOMA 3 0.0001
978 PROSTATE CANCER 6 0.0001
979 LUNG NEOPLASM MALIGNANT 3 0.0001
980 DRUG DOSE OMISSION 12 0.0001
981 NO ADVERSE EVENT 12 0.0001
982 ACNE 5 0.0001
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
984 DEVICE EXPULSION 4 0.0001
985 DEVICE MALFUNCTION 4 0.0001
986 NEOPLASM MALIGNANT 3 0.0000
987 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
988 TREATMENT FAILURE 3 0.0000
989 BREAST CANCER 3 0.0000
990 MALIGNANT NEOPLASM PROGRESSION 3 0.0000